MeSH tree: D23.050.865.450.500.750
First lady Jill Biden tested positive for COVID-19 and was experiencing "mild symptoms," the White House announced Tuesday. President Joe Biden continues to test negative after recently recovering from the virus but will ...
Aug 16, 2022
0
45
The EU's medicines watchdog said Wednesday it aims to approve this autumn a Pfizer/BioNTech COVID vaccine adapted for two fast-spreading subvariants of the Omicron strain.
Aug 10, 2022
0
50
Third and fourth BNT162b2 vaccine doses in adults aged 60 years or older are associated with a significant increase in antispike (anti-S) immunoglobulin G (IgG) antibody titers, according to a research letter published online ...
Jul 27, 2022
0
49
Twenty different COVID-19 variants were effectively identified and neutralized after a third booster, according to the new study for which the University of Surrey provided the crucial antigenic map of variants of concern.
Jul 25, 2022
0
236
In a technical tour de force, a collaborative team of Vanderbilt researchers has characterized the antigen-specific immune response to the Pfizer SARS-CoV-2 RNA vaccine.
Jul 22, 2022
0
100
President Joe Biden tested positive for COVID-19 on Thursday, is experiencing mild symptoms and has begun taking Paxlovid, an antiviral pill treatment.
Jul 22, 2022
0
33
Protection against severe COVID-19 by two doses of Pfizer-BioNTech and AstraZeneca COVID-19 vaccines remained high up to six months after second doses, finds new research which analysed NHS health record data on over seven ...
Jul 21, 2022
0
198
The rapid COVID-19 vaccine rollout from December 2020 averted infection in a large proportion of NHS hospital workers in England during the second wave of the pandemic, suggests research published by The BMJ today.
Jul 20, 2022
0
69
COVID vaccine producer Valneva suspended production on Wednesday after the European Commission massively ramped down a planned order of millions of doses.
Jul 20, 2022
0
66
Among children aged 5 to 11 years, most reported adverse events to BNT162b2 COVID-19 vaccination are mild-to-moderate, with few reports of myocarditis, according to a study recently published in Pediatrics.
Jul 11, 2022
0
43
